'In the Peripheral Stent Market, the Development of Next Generation Technology Has a Significant Benefit to Reducing the Risk of Restenosis and Improving the Ease of Implantation'.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c45655) has announced the addition of U.S. Peripheral Vascular Stent stent (stent) 1. a device or mold of a suitable material, used to hold a skin graft in place. 2. a slender rodlike or threadlike device used to provide support for tubular structures that are being anastomosed, or and Stent Grafts Difference Between a Stent Graft and a Stent A stent graft is a tubular device, which is composed of special fabric supported by a rigid structure, usually metal. The rigid structure is called a stent. Markets to their offering. This Frost & Sullivan research service entitled U.S. Peripheral Vascular Stent and Stent Grafts Market provides an overview of the trends and technologies that have shaped market revenue, market share, and implantation implantation /im·plan·ta·tion/ (im?plan-ta´shun) 1. attachment of the blastocyst to the epithelial lining of the uterus, its penetration through the epithelium, and, in humans, its embedding in the stratum compactum of the rates in the individual segments of the market. In this research, Frost & Sullivans expert analysts thoroughly examine the following markets: Aortic Aneurysms Aortic Aneurysm Definition An aneurysm is an abnormal bulging or swelling of a portion of a blood vessel. The aorta, which can develop these abnormal bulges, is the large blood vessel that carries oxygen-rich blood away from the heart to the rest of the Grafts, Renal, Iliac, and Biliary stents biliary stent Biliary endoprosthesis Surgery A tube inserted into a stenosed or obstructed narrowed or blocked bile duct to improve bile flow , in addition to stents used in the lower extremity lower extremity n. The hip, thigh, leg, ankle, or foot. Also called inferior limb, pelvic limb. , including foropopliteal arteries and below the leg. Market Sector Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this analysis: * Cardiovascular Devices * Stents Technologies The following technologies are covered in this research: * Self Expanding Stents * Bioadsorbable * Rapid Exchange * Microcoils * Liquid Embolics Market Overview Due to the plethora of devices with similar features vying for the market, being able to develop a robust technologically advanced product line will be critical to improving the chance a device witnesses high levels of success upon launch. In the peripheral stent market, the development of next generation technology such as drug eluting capabilities, in situ In place. When something is "in situ," it is in its original location. stent control or bioadsorbable device, each technological feature has a significant benefit to reducing the risk of restenosis and improving the ease of implantation. Developing and launching a device that fails to offer a significant benefit over competing devices, forces that device to compete against a high degree of negative market challenges. Firms need to make themselves aware of the features that will best serve the market six to seven years down the line, when those products would have completed regulatory approval and be ready for market launch. 1. Executive Summary 2. Total U.S. Peripheral Vascular Stent and Stent Grafts Market 3. Aortic Aneurysm Stent Grafts Market 4. Renal Iliac and Biliary Stents Market 5. Femoral-Popliteal Stent Market 6. Decision Support Databases For more information visit http://www.researchandmarkets.com/reports/c45655 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion